Back to results
US 2015/0306214 A1Published application
Adjuvant for mucosal vaccine
AssigneesDaiichi Sankyo Company, Limited, Osaka University
InventorsYukako Fujinaga, Takuhiro Matsumura, Masahiro Yutani, Nao Jonai
Life of this patent
Estimating the term…
Abstract
An object of the present invention is to provide an adjuvant for a mucosal vaccine with high safety that induces a sufficient immune response on the mucosa. According to the present invention, an adjuvant for a mucosal vaccine comprising a protein complex composed of hemagglutinin (HA) subcomponents HA1, HA2, and HA3 of botulinum toxin is provided.
Claims11
An adjuvant for a mucosal vaccine comprising a protein complex composed of hemagglutinin (HA) subcomponents HA1, HA2, and HA3 of botulinum toxin.
Dependencies are inferred from the claim text.